Drug
Itepekimab Sar440340
Itepekimab Sar440340: highest development phase Phase 2, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Itepekimab SAR440340 NCT05326412 | Phase 2 | Chronic Obstructive Pulmonary Disease |
Latest
No recent events.
Follow Itepekimab Sar440340 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.